A Study of Prevalence of EGFR Mutations in Participants With NSCLC
Completed
- Conditions
- Non-Small Cell Lung Cancer
- Registration Number
- NCT02695849
- Lead Sponsor
- Hoffmann-La Roche
- Brief Summary
This is a non-interventional, local, multicenter, cross-sectional study to determine the prevalence of epidermal growth factor receptor (EGFR) mutations in participants diagnosed with non-squamous non-small cell lung cancer (NSCLC).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 69
Inclusion Criteria
- Informed consent form signature
- Jordanian male and female participants greater than or equal to (>=) 18 years of age
- Histologically confirmed NSCLC
- Not participating in a study that involves an investigational agent within 30 days prior to enrollment
Read More
Exclusion Criteria
- Other primary malignancy
- Fine needle aspiration samples
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of Participants with EGFR mutations Day 1
- Secondary Outcome Measures
Name Time Method Percentage of Participants with types of EGFR mutations Day 1